Etranacogene dezaparvovecMeSH Supplementary Concept

https://ansm.sante.fr/tableau-marr/etranacogene-dezaparvovec
2025
false
false
false
France
French
risk management
Etranacogene Dezaparvovec
etranacogene dezaparvovec
guidelines for drug use
patients guideline
popular works
thromboembolism
Drug-Related side effects and adverse reactions
Chemical and Drug Induced Liver Injury
gene therapy
Gene Therapy Agents
semen
blood
DNA-Mediated Gene Transfer
pregnancy
gene transfer, horizontal
etranacogene dezaparvovec

---
https://www.has-sante.fr/jcms/p_3460133/fr/hemgenix-etranacogene-dezaparvovec-hemophilie-b
2023
false
false
false
France
Etranacogene Dezaparvovec
treatment outcome
insurance, health, reimbursement
adult
infusions, intravenous
gene therapy
Gene Therapy Agent
biological products
etranacogene dezaparvovec
etranacogene dezaparvovec
evaluation of the transparency committee
hemophilia B

---
https://www.has-sante.fr/jcms/p_3444027/fr/hemgenix-etranacogene-dezaparvovec-hemophilie-b
2023
false
false
false
France
adult
treatment outcome
Etranacogene Dezaparvovec
genetic therapy
hemophilia B
etranacogene dezaparvovec
etranacogene dezaparvovec
evaluation of the transparency committee
hemophilia B

---
https://www.ema.europa.eu/en/medicines/human/EPAR/hemgenix
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Etranacogene Dezaparvovec
Etranacogene Dezaparvovec
etranacogene dezaparvovec
gene therapy
orphan drug production
adult
hemophilia B
hemorrhage
infusions, intravenous
factor IX
F9 Gene
product surveillance, postmarketing
drug interactions
pregnancy
drug evaluation, preclinical
etranacogene dezaparvovec
etranacogene dezaparvovec

---